Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 66,512 | 44,521 | 21,426 | 27,772 | 11,400 |
| Gross Profit | 66,512 | 44,521 | 21,426 | 27,772 | 11,400 |
| Operating Expenses | 427,838 | 291,549 | 172,673 | 100,349 | 63,044 |
| Operating Income | -361,326 | -247,028 | -151,247 | -72,577 | -51,644 |
| Interest Expense | 0 | 0 | 0 | 469 | 696 |
| Other Income | 13,632 | 10,386 | 3,128 | 551 | -429 |
| Pre-tax Income | -347,694 | -236,642 | -148,119 | -72,495 | -52,769 |
| Net Income Continuous | -347,694 | -236,642 | -148,119 | -72,495 | -52,769 |
| Net Income | $-347,694 | $-236,642 | $-148,119 | $-72,495 | $-52,769 |
| EPS Basic Total Ops | -7.27 | -5.39 | -3.92 | -2.64 | -3.07 |
| EPS Basic Continuous Ops | -7.27 | -5.39 | -3.92 | -2.64 | -2.89 |
| EPS Diluted Total Ops | -7.27 | -5.39 | -3.92 | -2.64 | -3.07 |
| EPS Diluted Continuous Ops | -7.27 | -5.39 | -3.92 | -2.64 | -2.89 |
| EPS Diluted Before Non-Recurring Items | -7.27 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-361,016 | $-247,163 | $-149,989 | $-70,694 | $-50,696 |